Hand-out
Press Releases
CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina
With approval from ANMAT, CereVasc has initiated enrollment of the STRIDE trial in Argentina